Cart
sales@molnova.com
Dexamethasone 9,11-epoxide
CAS No. 24916-90-3
Dexamethasone 9,11-epoxide( —— )
Catalog No. M24136 CAS No. 24916-90-3
Dexamethasone 9,11-epoxide is a compound obtained by extraction and is an intermediate in the preparation of dexamethasone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 50MG | 33 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 132 | In Stock |
|
| 1G | 184 | In Stock |
|
Biological Information
-
Product NameDexamethasone 9,11-epoxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDexamethasone 9,11-epoxide is a compound obtained by extraction and is an intermediate in the preparation of dexamethasone.
-
DescriptionDexamethasone 9,11-epoxide is a compound obtained by extraction and is an intermediate in the preparation of dexamethasone.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24916-90-3
-
Formula Weight372.45
-
Molecular FormulaC22H28O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:95mg/mL 255.07 mM;Need ultrasonic);H2O: < 0.1 mg/mL (insoluble)
-
SMILESC[C@@]12[C@](C(CO)=O)(O)[C@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@]3(O5)[C@]5([H])C2)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Annaosanchun
Annaosanchun(YC-6) is potentially for the treatment of acute ischemic stroke (AIS).
-
Cephaeline dihydrobr...
Reference standards.
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
